PYXS – pyxis oncology, inc. (US:NASDAQ)
Stock Stats
News
Pyxis Oncology (NASDAQ:PYXS) had its "overweight" rating reaffirmed by analysts at Stephens.
Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Pyxis Oncology (NASDAQ:PYXS) was given a new $7.00 price target on by analysts at Guggenheim.
Pyxis Oncology to Participate in Upcoming Investor Conferences
Pyxis Oncology (NASDAQ:PYXS) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $9.00 price target on the stock.
Form S-3 Pyxis Oncology, Inc.
Form 10-Q Pyxis Oncology, Inc. For: Sep 30
Form 8-K Pyxis Oncology, Inc. For: Nov 03
Form SCHEDULE 13G/A Pyxis Oncology, Inc. Filed by: MILLENNIUM MANAGEMENT LLC
Form SCHEDULE 13G Pyxis Oncology, Inc. Filed by: GordonMD Global Investments LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.